November 2014 - FRMC

Investigation of Canagliflozin Use in a Real-World Setting

11/14/2014

Eileen Koutnik-Fotopoulos

In a new study, researchers investigated the demographic and clinical factors of patients initiating canagliflozin or DPP-4 therapy in a large commercially insured US population.

In a new study, researchers...

11/14/2014

First Report Managed Care

Study Examines Cost-Effectiveness of Interferon for MS

11/14/2014

Eileen Koutnik-Fotopoulos

Clinical data from the EVIDENCE study found that the cost-effectiveness of subcutaneous interferon (IFN) ß-1a 44 mcg given 3 times weekly was favorable compared with intramuscular IFN ß-1a 30 mcg given once weekly for relapsing forms of...

Clinical data from the EVIDENCE...

11/14/2014

First Report Managed Care

Examining Breakthrough Designation Labeling

11/14/2014

Kerri Fitzgerald

Breakthrough therapy designation was established as part of the FDA Safety and Innovation Act of 2012.

Breakthrough therapy designation...

11/14/2014

First Report Managed Care

Budget Model Analyzes Formulary Costs for Obesity Drugs

11/14/2014

Eileen Koutnik-Fotopoulos

A recent study evaluated formulary cost implications associated with the addition of naltrexone/bupropion for the treatment of obesity in the United States.

A recent study evaluated...

11/14/2014

First Report Managed Care

Tbo-Filgrastim Shows Significant Cost Saving for Payers

11/14/2014

Eileen Koutnik-Fotopoulos

A pharmacy budget impact model to estimate, from a payer perspective, the impact of the introduction of tbo-filgrastim as an alternative short-acting granulocyte colony-stimulating factor on a pharmacy budget showed a total annual plan cost...

A pharmacy budget impact model...

11/14/2014

First Report Managed Care

More Generics, Biosimilars, and Orphan Drugs on the Horizon

11/14/2014

Jill Sederstrom

As patented products expire, >$13 billion in brand-name specialty medications are expected to face generic competition in the next 5 years, and it is projected that there is a $31.8 billion opportunity in the market for biosimilars through...

As patented products expire,...

11/14/2014

First Report Managed Care

Tools to Help Payers Manage Growing Drug Costs

11/14/2014

Mary Beth Nierengarten

As with other specialty drugs, the high cost of medications to treat hepatitis C presents payers with the challenge of helping their members get the medications they need, while attempting to maintain healthcare costs.

As with other specialty drugs,...

11/14/2014

First Report Managed Care

News

Study Examines Costs for Various Psoriasis Treatments

11/14/2014

Eileen Koutnik-Fotopoulos

The economic burden of psoriasis in the United States is significant, as it is estimated to cost $11.25 billion annually in total direct and indirect healthcare costs, according to statistics from the National Psoriasis Foundation.

The economic burden of psoriasis...

11/14/2014

First Report Managed Care

Department

Conference Insider

AMCP Addresses Stance on Federal and State Legislative and Regulatory Moves

11/14/2014

Jill Sederstrom

Legislation on medication therapy management expansion and Medicare drug price negotiations are being discussed on the federal level, while states are considering legislation in the areas of biosimilars, controlled substances, and benefit...

Legislation on medication...

11/14/2014

First Report Managed Care

Conference Insider

Paradigm Change: New Guidelines on Managing Cholesterol

11/14/2014

Mary Beth Nierengarten

“This is a large paradigm change for clinicians,” said Joseph Saseen, PharmD, professor, vice chair, department of clinical pharmacy, professor, department of family medicine, University of Colorado Skaggs School of Pharmacy and...

“This is a large paradigm change...

11/14/2014

First Report Managed Care

Current Issue

March 2024

Volume 21

Issue 1

Current Issue

Issue Archive

What's Trending?

Silver Loading: Impact on 2019 Premiums

05/18/2018

Mary Beth Nierengarten

Repealing the cost-sharing subsidies for insurers has led to the practice of “silver-loading,” in which payers increase the prices of silver plans to maximize federal subsidies.

Repealing the...

05/18/2018

First Report Managed Care

Commentary

2024 CMS Advance Notice: Impact to Star Ratings, Focus on Health Equity, Part D, and Inflation Reduction Act

02/07/2023

Cory Busse, vice president, sales and strategic solutions, Icario

Cory Busse, vice president, sales and...

In this commentary, Cory Busse, vice president, sales and strategic solutions, Icario, reviews key takeaways for health plans from the Centers for Medicare & Medicaid Services' 2024 Advance Notice.

In this commentary, Cory Busse,...

02/07/2023

First Report Managed Care

Commentary

How Medicare Advantage Plans Can Prepare for the CMS Health Equity Index

02/13/2024

Christie Teigland, PhD, VP of Research Science and Advanced Analytics, Inovalon

Christie Teigland, PhD, VP of Researc...

As part of the 2024 Medicare Advantage (MA) and Part D Final Rule, CMS is enhancing the Star Ratings program by implementing a Health Equity Index (HEI) reward to incentivize MA and Part D contracts with 500 or more members to address...

As part of the 2024 Medicare...

02/13/2024

First Report Managed Care

Conference Insider

Health Plan VP Shares the Secret for Success in Value-Based Care

12/21/2018

A population health model focused on health and wellness is the key to success in value-based care, Cary B. Shames, DO, CHCQM, ABQAURP, vice president and chief medical officer at Sharp Health Plan explained at NAMCP.

A population health model...

12/21/2018

First Report Managed Care

News

Michigan to take lead in lawsuits against Obama`s birth control mandate in health care plans

02/13/2012

First Report Managed Care

Video Insights

Videos

Personalizing Weight Loss Management With GLP-1 Agonists

04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc

Featuring Tejaswi Kompala, MD, head o...

Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.

Delve into the rising demand for...

04/05/2024

First Report Managed Care

Videos

Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health

03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...

Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...

Join us for the continuation of...

03/27/2024

First Report Managed Care

Videos

Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care

03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...

Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...

Come join us for the first...

03/25/2024

First Report Managed Care

Videos

Navigating the Evolution of Digital Solutions in Health Care

02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates

Featuring Yash Prajapati, consultant ...

Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.

Join us in exploring the...

02/27/2024

First Report Managed Care

Videos

Advancements and Challenges in Diabetes Management

02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health

Featuring Mansur Shomali, MD, chief m...

Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.

Learn about the state of digital...

02/27/2024

First Report Managed Care

Videos

Costs and Benefits: How a New Cholesterol-Lowering Drug Compares to Others

10/24/2023

Featuring Kevin Cowart, PharmD, MPH, BCACP, CDCES

Featuring Kevin Cowart, PharmD, MPH, ...

Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.

Dr Kevin Cowart, assistant...

10/24/2023

First Report Managed Care

Videos

Biosimilars, Explained

10/24/2023

Featuring John Hennessey, MBA

In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.

In this video, John Hennessey,...

10/24/2023

First Report Managed Care

Videos

AVAHO 2023: Andrew Brunner, MD, Discusses Updates in MDS

10/20/2023

Featuring Andrew Brunner, MD

In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.

In this video, Dr Brunner...

10/20/2023

First Report Managed Care

Videos

A Dermatologist's Perspective on Demodex Blepharitis: Causes, Symptoms, and Treatment Options

10/19/2023

Featuring Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser

Featuring Katarina Kesty, MD, MBA, FA...

Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...

November 2014 - FRMC

News

Department

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

November 2014 Volume 11 Issue 11

Specialties

Events

Year Round Education

HMP Global Products